Visceral leishmaniasis and COVID-19 coinfection - A case report

Antonis Pikoulas; Evangelia-Theophano Piperaki; Gregory Spanakos; Anastasios Kallianos; Despoina Mparmparousi; Gianna Rentziou; Georgia Trakada

doi:10.1016/j.idcr.2021.e01358

Visceral leishmaniasis and COVID-19 coinfection - A case report

IDCases. 2022:27:e01358. doi: 10.1016/j.idcr.2021.e01358. Epub 2021 Dec 6.

Authors

Antonis Pikoulas^{1

2}, Evangelia-Theophano Piperaki³, Gregory Spanakos⁴, Anastasios Kallianos¹, Despoina Mparmparousi¹, Gianna Rentziou¹, Georgia Trakada¹

Affiliations

¹ Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
² Department of Medicine, University of Crete and Foundation for Research and Technology, Heraklion, Greece.
³ Department of Microbiology, Medical School, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
⁴ National Public Health Organization, Vari, Greece.

Abstract

As the COVID-19 pandemic spreads across the globe, it will undoubtedly cross paths with long endemic infectious diseases in different areas. Interactions between SARS-CoV2 and well-known pathogens will likely give rise to unfamiliar clinical presentations, depending on complex and as yet unknown immunological interactions. We present a case of coinfection with COVI19 and visceral leishmaniasis and discuss recent reports regarding coexistence of SARS-CoV2 and Leishmania spp. to date.

Keywords: COVID-19; Co-infection; SARS-CoV2; Visceral leishmaniasis.

Publication types

Case Reports